Modulation of the Coagulation Cascade Using Aptamers

Arteriosclerosis, Thrombosis, and Vascular Biology
R S Woodruff, B A Sullenger

Abstract

As a novel class of therapeutics, aptamers, or nucleic acid ligands, have garnered clinical interest because of the ease of isolating a highly specific aptamer against a wide range of targets, their chemical flexibility and synthesis, and their inherent ability to have their function reversed. The following review details the development and molecular mechanisms of aptamers targeting specific proteases in the coagulation cascade. The ability of these anticoagulant aptamers to bind to and inhibit exosite function rather than binding within the active site highlights the importance of exosites in blocking protein function. As both exosite inhibitors and reversible agents, the use of aptamers is a promising strategy for future therapeutics.

References

Aug 30, 1990·Nature·A D Ellington, J W Szostak
Jan 1, 1983·International Archives of Allergy and Applied Immunology·A W Richter, E Akerblom
Jan 1, 1995·Annual Review of Biochemistry·L GoldM Yarus
Aug 1, 1994·The Annals of Thoracic Surgery·A DeAndaD C Miller
Nov 22, 1997·Journal of Molecular Biology·D M TassetW Steiner
Dec 12, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·R WhiteB Sullenger
Sep 6, 2002·Nature·Christopher P RusconiBruce A Sullenger
Sep 5, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Chanan-KhanF M Muggia
Mar 1, 1996·Acta Crystallographica. Section D, Biological Crystallography·K Padmanabhan, A Tulinsky
Oct 27, 2004·Nature Biotechnology·Christopher P RusconiBruce A Sullenger
Jan 15, 2005·Pharmaceutical Research·Judith M HealyThomas G McCauley
Mar 30, 2005·Trends in Cardiovascular Medicine·Shahid M NimjeeBruce A Sullenger
May 27, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Ty E Adams, James A Huntington
Jun 13, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shahid M NimjeeBruce A Sullenger
Feb 21, 2008·Journal of Thrombosis and Haemostasis : JTH·M Y ChanR C Becker
Jul 23, 2008·Current Opinion in Chemical Biology·Anthony D Keefe, Sharon T Cload
Oct 2, 2008·Journal of Thrombosis and Haemostasis : JTH·J MüllerB Pötzsch
Oct 31, 2008·RNA·Stephen B LongBruce A Sullenger
Oct 6, 2009·Nature Medicine·Sabah OneyBruce A Sullenger
Oct 23, 2009·RNA·Shahid M NimjeeBruce A Sullenger
Dec 22, 2009·The Journal of Biological Chemistry·Sai K BuddaiSriram Krishnaswamy
Feb 6, 2010·Thrombosis and Haemostasis·Richard C BeckerBruce Sullenger
Jul 2, 2010·Nature Reviews. Drug Discovery·Anthony D KeefeAndrew Ellington
Sep 22, 2010·American Journal of Clinical Pathology·Geoffrey S Baird
Nov 17, 2010·Journal of Cardiovascular Translational Research·Thomas J PovsicRichard C Becker
Nov 27, 2010·Expert Review of Cardiovascular Therapy·Christa FirbasBernd Jilma
Dec 22, 2010·Thrombosis and Haemostasis·Petra Jilma-StohlawetzPaul Knöbl
Jun 28, 2011·Stroke; a Journal of Cerebral Circulation·Hugh S MarkusAlice King

❮ Previous
Next ❯

Citations

Feb 2, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Prabodhika Mallikaratchy
May 10, 2016·International Journal of Biological Macromolecules·Kinjal A PatelIpsita Roy
Jan 10, 2018·Frontiers in Pharmacology·Elena ZavyalovaGalina Pavlova
Sep 28, 2017·Expert Opinion on Drug Discovery·Antonio Gómez-OutesMª Luisa Suárez-Gea
Jul 18, 2018·Current Opinion in Hematology·Charlene V ChabataRuwan Gunaratne
Feb 13, 2018·RNA Biology·Jyoti BalaHoshang Unwalla
Dec 19, 2019·Expert Opinion on Therapeutic Patents·Rami A Al-Horani
Jun 22, 2017·Cancers·Marie-Cécile MercierLaurence Choulier
Oct 24, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Carolina RoxoAnna Pasternak
Dec 19, 2020·Molecular Therapy. Nucleic Acids·Jiabiao HuVictor J Dzau
Aug 11, 2020·Pharmacology & Therapeutics·Claudia RiccardiDaniela Montesarchio
Jun 23, 2021·Chemical Reviews·Abhichart KrissanaprasitThomas H LaBean
Jul 19, 2017·Journal of the American Chemical Society·Vandana LambaDaniel Herschlag
Jan 22, 2020·Journal of the American Chemical Society·Qian ShaoFloyd E Romesberg
Jul 23, 2021·Angewandte Chemie·Patricia MüllerAlexander Heckel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.